Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules

被引：40

作者：

Davis, JL

Smith, RL

机构：

来源：

DIABETES CARE | 1999年 / 22卷 / 11期

关键词：

D O I：

10.2337/diacare.22.11.1909

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1909 / 1910

页数：2

共 11 条

[1] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].

Backonja, M ;

Beydoun, A ;

Edwards, KR ;

Schwartz, SL ;

Fonseca, V ;

Hes, M ;

LaMoreaux, L ;

Garofalo, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836

[2] PATHOGENESIS AND PREVENTION OF DIABETIC NEUROPATHY [J].

GREENE, DA ;

LATTIMER, SA ;

SIMA, AAF .

DIABETES-METABOLISM REVIEWS, 1988, 4 (03) :201-221

[3] CLINICAL-TRIAL OF AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY [J].

HANDELSMAN, DJ ;

TURTLE, JR .

DIABETES, 1981, 30 (06) :459-464

[4] EFFECTS OF DESIPRAMINE, AMITRIPTYLINE, AND FLUOXETINE ON PAIN IN DIABETIC NEUROPATHY [J].

MAX, MB ;

LYNCH, SA ;

MUIR, J ;

SHOAF, SE ;

SMOLLER, B ;

DUBNER, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) :1250-1256

[5] VENLAFAXINE - A STRUCTURALLY UNIQUE AND NOVEL ANTIDEPRESSANT [J].

MORTON, WA ;

SONNE, SC ;

VERGA, MA .

ANNALS OF PHARMACOTHERAPY, 1995, 29 (04) :387-395

[6] Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy [J].

Oskarsson, P ;

Ljunggren, JG ;

Lins, PE ;

Bolinder, J ;

Bystedt, T ;

Engstrom, L ;

Olsson, PO ;

Gamstedt, A ;

Fagerberg, SE ;

Nordlander, S ;

Gertow, O ;

Lennerhagen, P ;

Lithner, F ;

Svedberg, E ;

Hartikkainen, P ;

Makinen, T .

DIABETES CARE, 1997, 20 (10) :1594-1597

[7] SYMPTOMATIC TREATMENT OF PERIPHERAL DIABETIC NEUROPATHY WITH CARBAMAZEPINE (TEGRETOL) - DOUBLE BLIND CROSSOVER TRIAL [J].

RULL, JA ;

QUIBRERA, R ;

GONZALEZ.H ;

CASTANED.OL .

DIABETOLOGIA, 1969, 5 (04) :215-&

[8] THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].

SHAMOON, H ;

DUFFY, H ;

FLEISCHER, N ;

ENGEL, S ;

SAENGER, P ;

STRELZYN, M ;

LITWAK, M ;

WYLIEROSETT, J ;

FARKASH, A ;

GEIGER, D ;

ENGEL, H ;

FLEISCHMAN, J ;

POMPI, D ;

GINSBERG, N ;

GLOVER, M ;

BRISMAN, M ;

WALKER, E ;

THOMASHUNIS, A ;

GONZALEZ, J ;

GENUTH, S ;

BROWN, E ;

DAHMS, W ;

PUGSLEY, P ;

MAYER, L ;

KERR, D ;

LANDAU, B ;

SINGERMAN, L ;

RICE, T ;

NOVAK, M ;

SMITHBREWER, S ;

MCCONNELL, J ;

DROTAR, D ;

WOODS, D ;

KATIRGI, B ;

LITVENE, M ;

BROWN, C ;

LUSK, M ;

CAMPBELL, R ;

LACKAYE, M ;

RICHARDSON, M ;

LEVY, B ;

CHANG, S ;

HEINHEINEMANN, M ;

BARRON, S ;

ASTOR, L ;

LEBECK, D ;

BRILLON, D ;

DIAMOND, B ;

VASILASDWOSKIN, A ;

LAURENZI, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986

[9] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].

Turner, RC ;

Holman, RR ;

Cull, CA ;

Stratton, IM ;

Matthews, DR ;

Frighi, V ;

Manley, SE ;

Neil, A ;

McElroy, K ;

Wright, D ;

Kohner, E ;

Fox, C ;

Hadden, D ;

Mehta, Z ;

Smith, A ;

Nugent, Z ;

Peto, R ;

Adlel, AI ;

Mann, JI ;

Bassett, PA ;

Oakes, SF ;

Dornan, TL ;

Aldington, S ;

Lipinski, H ;

Collum, R ;

Harrison, K ;

MacIntyre, C ;

Skinner, S ;

Mortemore, A ;

Nelson, D ;

Cockley, S ;

Levien, S ;

Bodsworth, L ;

Willox, R ;

Biggs, T ;

Dove, S ;

Beattie, E ;

Gradwell, M ;

Staples, S ;

Lam, R ;

Taylor, F ;

Leung, L ;

Carter, RD ;

Brownlee, SM ;

Fisher, KE ;

Islam, K ;

Jelfs, R ;

Williams, PA ;

Williams, FA ;

Sutton, PJ .

LANCET, 1998, 352 (9131) :837-853

[10] BANTING LECTURE 1986 - DOES A COMMON MECHANISM INDUCE THE DIVERSE COMPLICATIONS OF DIABETES [J].

WINEGRAD, AI .

DIABETES, 1987, 36 (03) :396-405

← 1 2 →